This study demonstrates that [89Zr]Zr-DFO-N-suc-CSF1R-mAb is not exclusively targeting tumor macrophages but preferably distributes to other organs with high macrophage presence such as the liver and spleen, removing the antibody from circulation. This evidence concerns the gene CSF1R and neoplasm.